Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Chukyo Iyakuhin Co., Ltd. (4558:JPX), powered by AI.
Chukyo Iyakuhin Co., Ltd. is currently trading at ¥199. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Chukyo Iyakuhin Co., Ltd. on Alpha Lenz.
Chukyo Iyakuhin Co., Ltd.'s P/E ratio is 47.0.
“Chukyo Iyakuhin Co., Ltd. trades at a P/E of 47.0 (premium valuation) with modest ROE of 1.8%.”
Ask for details →Chukyo Iyakuhin Co., Ltd. is a pharmaceutical company based in Japan, primarily engaged in the development, production, and distribution of pharmaceutical products. Its primary function is to provide healthcare solutions through a diverse portfolio of medications that address various medical needs. The company focuses on producing ethical pharmaceuticals, including prescription drugs, which are used to treat chronic and acute illnesses. Additionally, Chukyo Iyakuhin Co., Ltd. manufactures over-the-counter medicines, catering to a wide range of common health concerns. Chukyo Iyakuhin Co., Ltd. plays a significant role in the healthcare industry, both domestically and internationally, by ensuring the availability of essential medications and contributing to the advancement of medical treatments. Its products are integral to hospitals, clinics, and pharmacies, highlighting its importance in the global supply chain of pharmaceutical goods. The company is also involved in research and development to foster innovation, aiming to improve healthcare outcomes through new drug discoveries. Overall, Chukyo Iyakuhin Co., Ltd. is a key player in the pharmaceutical market, addressing patient needs and supporting healthcare systems with a strong commitment to quality and efficacy.
“Chukyo Iyakuhin Co., Ltd. trades at a P/E of 47.0 (premium valuation) with modest ROE of 1.8%.”
Ask for details →Chukyo Iyakuhin Co., Ltd. (ticker: 4558) is a company listed on JPX in the Consumer Cyclical sector (Department Stores). It has approximately 607 employees. Market cap is $2.1B.
The current price is 199 with a P/E ratio of 46.96x and P/B of 0.84x.
ROE is 1.79% and operating margin is 1.68%. Annual revenue is $6.3B.